Assessing the impact of Movalis [meloxicam] on health related quality of life
Phase of Trial: Phase IV
Latest Information Update: 19 Feb 2015
At a glance
- Drugs Meloxicam (Primary)
- Indications Musculoskeletal pain; Osteoarthritis; Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 20 Nov 2009 Planned number of patients changed from 3531 to 3569, additional trial location identified as Croatia as reported by ClinicalTrials.gov.
- 12 Feb 2009 Actual initiation date (Mar 2007) added as reported by ClinicalTrials.gov.
- 12 Feb 2009 Planned number of patients changed from 4150 to 3531 as reported by ClinicalTrials.gov.